European Stocks

• European equities are trading near record peaks as a fresh wave of positive corporate earnings boosts investor risk appetite. • Market gains are being supported by a decline in crude oil prices, which has helped investors overlook mixed macroeconomic indicators. • This upward trend persists despite ongoing geopolitical uncertainty, signaling strong confidence in corporate performance.

• The STOXX Europe 600 index has reached record highs, driven by a combination of strong corporate earnings and positive macroeconomic data. • Eurozone GDP growth for Q2 2026 hit 0.4% quarter-to-quarter, exceeding consensus expectations by 0.2 percentage points. • According to Pantheon Macroeconomics' chief economist Claus Vistesen, this growth follows an upward revision to zero growth in Q1, signaling a recovery in the region.

• The STOXX Europe 600 Index reached a record closing high for the second consecutive day on May 5, though overall gains were tempered by shifting Middle East peace hopes. • Novo Nordisk shares plummeted 4.3% after sales of the oral version of its obesity drug, Wegovy, failed to meet market expectations despite an increase in 2026 full-year guidance. • In the pharmaceutical sector, reports from Reuters indicated that AstraZeneca is not currently engaged in concrete merger talks with any U.S. companies.

• European stock markets closed mostly higher on Monday, with the Stoxx Europe gaining 0.4%, Germany's DAX climbing 1.6%, and France's CAC advancing 1.4%. • Market activity was highlighted by reports that pharmaceutical giant AstraZeneca is currently in merger talks with Bristol Myers Squibb. • The positive momentum reflects broader optimism in the sector, while the S&P 500 is simultaneously approaching 40% earnings growth, driven largely by Alphabet.

• European high-momentum stocks, particularly those tied to AI, plummeted 14% relative to the broader market in July. • This decline reversed a significant 23% outperformance seen during the first half of the year, according to a BofA Securities report. • The sell-off was triggered by growing investor doubts regarding AI monetization and a sharp increase in funding costs for hyperscalers.

• European stocks reached record highs on Friday, continuing a period of outperformance compared to U.S. markets. • The rally was driven by strong corporate earnings and a surge in technology stocks, though gains were partially offset by a decline in Novo Nordisk A/S. • This trend highlights a shift in investor confidence toward European equities amid a broader global market rally.

• European stocks reached a record high on Friday, July 31, driven by strong corporate earnings and a global surge in investor appetite for technology shares. • The market rally persisted despite a volatile week characterized by critical central bank policy decisions and escalating hostilities in the Middle East. • This growth is significant as it positions European indices for a potential monthly gain, reflecting resilience in the face of geopolitical and macroeconomic uncertainty.